ANTX (STOCKS)
AN2 Therapeutics, Inc. Common Stock
$6.300000
+0.020000 (+0.32%)
Prev close: $6.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric Easom
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $254.40M
- Employees
- 36
- P/E (TTM)
- -5.57
- P/B (TTM)
- 3.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.29 | $-0.23 | -0.0554 | -23.61% |
|
Dec 2025 (Q4)
|
$-0.29 | $-0.24 | -0.0452 | -18.46% |
|
Sep 2025 (Q3)
|
$-0.31 | $-0.22 | -0.0856 | -38.15% |
|
Jun 2025 (Q2)
|
$-0.21 | $-0.34 | +0.1297 | +38.18% |
Financial Statements
| Assets | $81.68M |
| Current Assets | $79.99M |
| Noncurrent Assets | $1.69M |
| Liabilities | $5.76M |
| Current Liabilities | $5.59M |
| Accounts Payable | $1.97M |
| Wages | $1.10M |
| Other Current Liabilities | $2.52M |
| Noncurrent Liabilities | $170.00K |
| Equity | $75.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $75.92M |
| Liabilities And Equity | $81.68M |